77 related articles for article (PubMed ID: 11598493)
1. Cerebral glucose transport implies individualized glial cell function.
Feinendegen LE; Herzog H; Thompson KH
J Cereb Blood Flow Metab; 2001 Oct; 21(10):1160-70. PubMed ID: 11598493
[TBL] [Abstract][Full Text] [Related]
2. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
Brooks DJ; Beaney RP; Lammertsma AA; Herold S; Turton DR; Luthra SK; Frackowiak RS; Thomas DG; Marshall J; Jones T
J Cereb Blood Flow Metab; 1986 Apr; 6(2):230-9. PubMed ID: 3007547
[TBL] [Abstract][Full Text] [Related]
3. Glucose transport and utilization in the human brain: model using carbon-11 methylglucose and positron emission tomography.
Feinendegen LE; Herzog H; Wieler H; Patton DD; Schmid A
J Nucl Med; 1986 Dec; 27(12):1867-77. PubMed ID: 3491192
[TBL] [Abstract][Full Text] [Related]
4. Regional cerebral glucose transport in insulin-dependent diabetic patients studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
Brooks DJ; Gibbs JS; Sharp P; Herold S; Turton DR; Luthra SK; Kohner EM; Bloom SR; Jones T
J Cereb Blood Flow Metab; 1986 Apr; 6(2):240-4. PubMed ID: 3485643
[TBL] [Abstract][Full Text] [Related]
5. In vivo determination of the kinetic parameters of glucose transport in the human brain using 11C-methyl-D-glucose (CMG) and dynamic positron emission tomography (dPET).
Vyska K; Magloire JR; Freundlieb C; Höck A; Becker V; Schmid A; Feinendegen LE; Kloster G; Stöcklin G; Schuier FJ
Eur J Nucl Med; 1985; 11(4):97-106. PubMed ID: 3876936
[TBL] [Abstract][Full Text] [Related]
6. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
[TBL] [Abstract][Full Text] [Related]
7. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
[TBL] [Abstract][Full Text] [Related]
8. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
9. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans.
Hasselbalch SG; Knudsen GM; Videbaek C; Pinborg LH; Schmidt JF; Holm S; Paulson OB
Diabetes; 1999 Oct; 48(10):1915-21. PubMed ID: 10512354
[TBL] [Abstract][Full Text] [Related]
10. Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil.
Price JC; Mayberg HS; Dannals RF; Wilson AA; Ravert HT; Sadzot B; Rattner Z; Kimball A; Feldman MA; Frost JJ
J Cereb Blood Flow Metab; 1993 Jul; 13(4):656-67. PubMed ID: 8391018
[TBL] [Abstract][Full Text] [Related]
11. Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling.
Munk OL; Bass L; Roelsgaard K; Bender D; Hansen SB; Keiding S
J Nucl Med; 2001 May; 42(5):795-801. PubMed ID: 11337579
[TBL] [Abstract][Full Text] [Related]
12. [Kinetics of glucose metabolism in central neurocytomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Oct; 47(10):981-7. PubMed ID: 7577144
[TBL] [Abstract][Full Text] [Related]
13. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
Kuwabara H; Evans AC; Gjedde A
J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
[TBL] [Abstract][Full Text] [Related]
14. Diminished glucose transport in Alzheimer's disease: dynamic PET studies.
Jagust WJ; Seab JP; Huesman RH; Valk PE; Mathis CA; Reed BR; Coxson PG; Budinger TF
J Cereb Blood Flow Metab; 1991 Mar; 11(2):323-30. PubMed ID: 1997504
[TBL] [Abstract][Full Text] [Related]
15. Measurement of cerebral glucose utilization using washout after carotid injection in the rat.
Oldendorf WH; Pardridge WM; Braun LD; Crane PD
J Neurochem; 1982 May; 38(5):1413-8. PubMed ID: 7062059
[TBL] [Abstract][Full Text] [Related]
16. [Methyl-11C]thymidine positron emission tomography in tumoral and non-tumoral cerebral lesions.
De Reuck J; Santens P; Goethals P; Strijckmans K; Lemahieu I; Boon P; Achten E; Lemmerling M; Vandekerckhove T; Caemaert J
Acta Neurol Belg; 1999 Jun; 99(2):118-25. PubMed ID: 10427354
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of glucose transport in malignant glioma by PET.
Ishikawa M; Kikuchi H; Nishizawa S; Yonekura Y
Acta Neurochir Suppl (Wien); 1990; 51():165-7. PubMed ID: 2089886
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans.
Lerche S; Brock B; Rungby J; Bøtker HE; Møller N; Rodell A; Bibby BM; Holst JJ; Schmitz O; Gjedde A
Diabetes; 2008 Feb; 57(2):325-31. PubMed ID: 17991759
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia activates compensatory mechanism of glucose metabolism of brain.
Márián T; Balkay L; Fekete I; Lengyel Z; Veress G; Esik O; Trón L; Krasznai Z
Acta Biol Hung; 2001; 52(1):35-45. PubMed ID: 11396840
[TBL] [Abstract][Full Text] [Related]
20. A new graphic plot analysis for cerebral blood flow and partition coefficient with iodine-123-iodoamphetamine and dynamic SPECT validation studies using oxygen-15-water and PET.
Yokoi T; Iida H; Itoh H; Kanno I
J Nucl Med; 1993 Mar; 34(3):498-505. PubMed ID: 8441045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
